ConductScience.org, home

Paper40891745

Structural insights into Arylidenehydrazinyl Benzenesulfonamides as potent mycobacterial carbonic anhydrase inhibitors.

Kumar P and 11 others. Future Med Chem, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Structural insights into Arylidenehydrazinyl Benzenesulfonamides as potent mycobacterial carbonic anhydrase inhibitors. Papers, record 40891745. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40891745

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Structural insights into Arylidenehydrazinyl Benzenesulfonamides as potent mycobacterial carbonic anhydrase inhibitors.
PubMed
Journal
Future Med Chem
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-09-03
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kumar PPardeep
2Singampalli AAnuradha
3Bandela RRani
4Bellapukonda SMSri Mounika
5Maddipatla SSarvan
6Dalal AAman
7Devi AAnkita
8Nanduri SSrinivas
9Kalia NPNitin Pal
10Paoletti NNiccolohttps://orcid.org/0000-0002-6874-9419
11Supuran CTClaudiu Thttps://orcid.org/0000-0003-4262-0323
12Madhavi YVYaddanapudi Venkatahttps://orcid.org/0000-0002-9813-8694

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carbonic Anhydrase InhibitorsMajor topic
Mycobacterium tuberculosisMajor topic
SulfonamidesMajor topic
Carbonic AnhydrasesMajor topic
Antitubercular AgentsMajor topic
Humans
Microbial Sensitivity Tests
Molecular Docking Simulation
Structure-Activity Relationship
Molecular Structure
Molecular Dynamics Simulation
Benzenesulfonamides

Source PubMed

Download CSV of topics

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112657046Genes required for mycobacterial growth defined by high density mutagenesis.Mol Microbiol2003https://conductscience.org/library/papers/12657046PubMed
28795459Membrane carbonic anhydrase (IV) and ciliary epithelium. Carbonic anhydrase activity is present in the basolateral membranes of the non-pigmented ciliary epithelium of rabbit eyes.Exp Eye Res1996https://conductscience.org/library/papers/8795459PubMed
315028762Carbonic anhydrase isoform VII acts as a molecular switch in the development of synchronous gamma-frequency firing of hippocampal CA1 pyramidal cells.J Neurosci2004https://conductscience.org/library/papers/15028762PubMed
414600151Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family.J Biol Chem2004https://conductscience.org/library/papers/14600151PubMed
510649985Carbonic anhydrase inhibitors: synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes.J Med Chem2000https://conductscience.org/library/papers/10649985PubMed
619211803Pathogenesis of retinitis pigmentosa associated with apoptosis-inducing mutations in carbonic anhydrase IV.Proc Natl Acad Sci U S A2009https://conductscience.org/library/papers/19211803PubMed
740613379Exploration of pyrazole-based pyridine-4-carbohydrazide derivatives as drug-resistant Mtb agents: design, synthesis, biological evaluation, and in-silico studies.Future Med Chem2025https://conductscience.org/library/papers/40613379PubMed
818167490Carbonic anhydrases: novel therapeutic applications for inhibitors and activators.Nat Rev Drug Discov2008https://conductscience.org/library/papers/18167490PubMed
923265903Inhibition of the β-carbonic anhydrases from Mycobacterium tuberculosis with C-cinnamoyl glycosides: identification of the first inhibitor with anti-mycobacterial activity.Bioorg Med Chem Lett2013https://conductscience.org/library/papers/23265903PubMed
1040817577Exploration of New Dihydroindazole Derivatives as Promising Anti-TB Agents: Design, Synthesis, In Silico, and Biological Evaluation.Arch Pharm (Weinheim)2025https://conductscience.org/library/papers/40817577PubMed
1137241761Inhibition Studies on Human and Mycobacterial Carbonic Anhydrases with N-((4-Sulfamoylphenyl)carbamothioyl) Amides.Molecules2023https://conductscience.org/library/papers/37241761PubMed
1239222997Mycobacterial β-carbonic anhydrases: Molecular biology, role in the pathogenesis of tuberculosis and inhibition studies.Enzymes2024https://conductscience.org/library/papers/39222997PubMed
1312676895Expression of cell surface transmembrane carbonic anhydrase genes CA9 and CA12 in the human eye: overexpression of CA12 (CAXII) in glaucoma.J Med Genet2003https://conductscience.org/library/papers/12676895PubMed
1438473830Benzothiadiazinone-1,1-Dioxide Carbonic Anhydrase Inhibitors Suppress the Growth of Drug-Resistant Mycobacterium tuberculosis Strains.Int J Mol Sci2024https://conductscience.org/library/papers/38473830PubMed
1531627429Mycobacterium tuberculosis β-Carbonic Anhydrases: Novel Targets for Developing Antituberculosis Drugs.Int J Mol Sci2019https://conductscience.org/library/papers/31627429PubMed
1618274517Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances.Nat Protoc2008https://conductscience.org/library/papers/18274517PubMed
1717482815Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.Bioorg Med Chem Lett2007https://conductscience.org/library/papers/17482815PubMed
1839191032Recent advances and challenges of revolutionizing drug-resistant tuberculosis treatment.Eur J Med Chem2024https://conductscience.org/library/papers/39191032PubMed
1924156740Sulfonamides incorporating fluorine and 1,3,5-triazine moieties are effective inhibitors of three β-class carbonic anhydrases from Mycobacterium tuberculosis.J Enzyme Inhib Med Chem2014https://conductscience.org/library/papers/24156740PubMed
2019703035Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates?Chem Biol Drug Des2009https://conductscience.org/library/papers/19703035PubMed

See all 50 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
42760852Design, Synthesis, Antimycobacterial Evaluation, and In Silico Investigation of Benzisothiazole-Based Hydrazide Derivatives as Potential Anti-Tuberculosis Agents.Chem Biol Drug Des2026https://conductscience.org/library/papers/42760852

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CYP24A11591PubTator's text mininghttps://conductscience.org/library/genes/1591

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40891745

GET https://conductscience.org/api/papers/v1/40891745/references?page=2